Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check2 days agoChange DetectedThe study record revision was updated from v3.5.3 to v3.5.4, reflecting a new document revision in the study history. This change indicates an update to the study documentation on ClinicalTrials.gov.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows a revision update from v3.5.2 to v3.5.3, indicating a minor metadata/build change. This does not modify the study details or content presented on the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedPage revision updated to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page now displays Revision: v3.4.2 and the prior Revision: v3.4.1 notice has been removed; the change is metadata-related and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.